» Articles » PMID: 36068204

MVsim is a Toolset for Quantifying and Designing Multivalent Interactions

Overview
Journal Nat Commun
Specialty Biology
Date 2022 Sep 6
PMID 36068204
Authors
Affiliations
Soon will be listed here.
Abstract

Arising through multiple binding elements, multivalency can specify the avidity, duration, cooperativity, and selectivity of biomolecular interactions, but quantitative prediction and design of these properties has remained challenging. Here we present MVsim, an application suite built around a configurational network model of multivalency to facilitate the quantification, design, and mechanistic evaluation of multivalent binding phenomena through a simple graphical user interface. To demonstrate the utility and versatility of MVsim, we first show that both monospecific and multispecific multivalent ligand-receptor interactions, with their noncanonical binding kinetics, can be accurately simulated. Further, to illustrate the conceptual insights into multivalent systems that MVsim can provide, we apply it to quantitatively predict the ultrasensitivity and performance of multivalent-encoded protein logic gates, evaluate the inherent programmability of multispecificity for selective receptor targeting, and extract rate constants of conformational switching for the SARS-CoV-2 spike protein and model its binding to ACE2 as well as multivalent inhibitors of this interaction. MVsim and instructional tutorials are freely available at https://sarkarlab.github.io/MVsim/ .

Citing Articles

The molecular reach of antibodies crucially underpins their viral neutralisation capacity.

Huhn A, Nissley D, Wilson D, Kutuzov M, Donat R, Tan T Nat Commun. 2025; 16(1):338.

PMID: 39746910 PMC: 11695720. DOI: 10.1038/s41467-024-54916-5.


Facile Display of Homomultivalent Proteins for Selections.

Ohoka A, Sarkar C ACS Synth Biol. 2023; 12(2):634-638.

PMID: 36655840 PMC: 9985468. DOI: 10.1021/acssynbio.2c00563.


Modulating binding affinity, specificity, and configurations by multivalent interactions.

Deng Y, Efremov A, Yan J Biophys J. 2022; 121(10):1868-1880.

PMID: 35450827 PMC: 9199096. DOI: 10.1016/j.bpj.2022.04.017.

References
1.
Harvey W, Carabelli A, Jackson B, Gupta R, Thomson E, Harrison E . SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021; 19(7):409-424. PMC: 8167834. DOI: 10.1038/s41579-021-00573-0. View

2.
Zeke A, Lukacs M, Lim W, Remenyi A . Scaffolds: interaction platforms for cellular signalling circuits. Trends Cell Biol. 2009; 19(8):364-74. PMC: 3073007. DOI: 10.1016/j.tcb.2009.05.007. View

3.
Guo L, Bi W, Wang X, Xu W, Yan R, Zhang Y . Engineered trimeric ACE2 binds viral spike protein and locks it in "Three-up" conformation to potently inhibit SARS-CoV-2 infection. Cell Res. 2020; 31(1):98-100. PMC: 7656503. DOI: 10.1038/s41422-020-00438-w. View

4.
Lu M, Uchil P, Li W, Zheng D, Terry D, Gorman J . Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles. Cell Host Microbe. 2020; 28(6):880-891.e8. PMC: 7664471. DOI: 10.1016/j.chom.2020.11.001. View

5.
Michalski P, Loew L . SpringSaLaD: A Spatial, Particle-Based Biochemical Simulation Platform with Excluded Volume. Biophys J. 2016; 110(3):523-529. PMC: 4744174. DOI: 10.1016/j.bpj.2015.12.026. View